Troluce Capital Advisors’s GH Research GHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-990,472
Closed -$13.9M 58
2026
Q1
$13.9M Buy
990,472
+617,260
+165% +$9.47M 0.85% 40
2025
Q4
$4.74M Buy
373,212
+326,490
+699% +$4.45M 3.01% 10
2025
Q3
$668K Sell
46,722
-39,069
-46% -$547K 0.09% 36
2025
Q2
$1.05M Sell
85,791
-69,806
-45% -$765K 0.25% 24
2025
Q1
$1.72M Buy
+155,597
New +$1.74M 0.51% 23

Other funds holding GHRS

Troluce Capital Advisors's GHRS Position: Q2 2026 in Review

Troluce Capital Advisors sold out of GH Research (GHRS) in Q2 2026, closing a stake of 990,472 shares — an estimated $13.9M sold.

Troluce Capital Advisors first reported a position in GHRS in Q1 2025 and held it in 5 quarters. The position peaked at $13.9M in Q1 2026. 63 funds tracked by Wall St. Rank hold GHRS as of Q2 2026.

  • Troluce Capital Advisors reported no remaining GH Research position as of Q2 2026 after selling out during the quarter.
  • Troluce Capital Advisors sold 990,472 GH Research shares in Q2 2026, an estimated $13.9M.
  • Troluce Capital Advisors first reported a position in GH Research in Q1 2025 and held it in 5 quarters.
  • Troluce Capital Advisors's GH Research position peaked at $13.9M in Q1 2026.
  • 63 funds tracked by Wall St. Rank held GH Research as of Q2 2026.

Based on Troluce Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.